Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × zimberelimab × Genitourinary × Clear all

Phase

Status

Recruiting 4 Active not recruiting 3 Completed 2 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2 Gastrointestinal 2 Genitourinary 1 Endocrine 1 Breast 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Gemcitabine 14 Androgen Antagonists 14 Specimen Handling 13 Radiotherapy 11 Radiosurgery 10 pembrolizumab 8 darolutamide 8 Magnetic Resonance Spectroscopy 8 Nivolumab 7 Drug Therapy 7 Docetaxel 7 apalutamide 6 Biopsy 6 Abiraterone Acetate 6 toripalimab 5 Cystectomy 5 Cisplatin 5 Brachytherapy 5 lenvatinib 4 enzalutamide 4 disitamab vedotin 4 abiraterone 4 Standard of Care 4 Mitomycin 4 Ipilimumab 4 Axitinib 4 tislelizumab 3 cabozantinib 3 Sunitinib 3 Saline Solution 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06528483 2024-07-30

preSAVE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡